Philip Morris International is increasing investment in its Zyn nicotine pouches, launching new variants like Zyn Ultra to defend market share amid tougher competition, while still delivering a Q2 revenue beat. At the same time, the company trimmed its full-year profit guidance for a third time due to adverse currency effects and higher costs from the global environment.
